Germany · Delayed Price · Currency is EUR NANO MRNA Statistics
Total Valuation
NANO MRNA has a market cap or net worth of EUR 60.23 million. The enterprise value is 45.42 million.
| Market Cap | 60.23M |
| Enterprise Value | 45.42M |
Important Dates
The next estimated earnings date is Friday, February 13, 2026.
| Earnings Date | Feb 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 70.60M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.52% |
| Shares Change (QoQ) | +0.99% |
| Owned by Insiders (%) | 3.49% |
| Owned by Institutions (%) | 4.54% |
| Float | 62.78M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 73.64 |
| PB Ratio | 3.97 |
| P/TBV Ratio | 3.97 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -10.42 |
| EV / Sales | 57.74 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.10
| Current Ratio | 4.10 |
| Quick Ratio | 3.89 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -26.60% and return on invested capital (ROIC) is -14.34%.
| Return on Equity (ROE) | -26.60% |
| Return on Assets (ROA) | -12.01% |
| Return on Invested Capital (ROIC) | -14.34% |
| Return on Capital Employed (ROCE) | -29.02% |
| Revenue Per Employee | 40,890 |
| Profits Per Employee | -217,986 |
| Employee Count | 20 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NANO MRNA has paid 11,518 in taxes.
| Income Tax | 11,518 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -12.11% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -12.11% |
| 50-Day Moving Average | 0.80 |
| 200-Day Moving Average | 0.80 |
| Relative Strength Index (RSI) | 62.23 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NANO MRNA had revenue of EUR 817,808 and -4.36 million in losses. Loss per share was -0.06.
| Revenue | 817,808 |
| Gross Profit | 593,199 |
| Operating Income | -4.49M |
| Pretax Income | -4.35M |
| Net Income | -4.36M |
| EBITDA | n/a |
| EBIT | -4.49M |
| Loss Per Share | -0.06 |
Balance Sheet
The company has 15.39 million in cash and n/a in debt, giving a net cash position of 15.39 million.
| Cash & Cash Equivalents | 15.39M |
| Total Debt | n/a |
| Net Cash | 15.39M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 15.17M |
| Book Value Per Share | 0.21 |
| Working Capital | 12.32M |
Cash Flow
| Operating Cash Flow | -2.56M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 72.54% |
| Operating Margin | -549.30% |
| Pretax Margin | -531.69% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NANO MRNA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.52% |
| Shareholder Yield | -0.52% |
| Earnings Yield | -7.24% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 27, 2014. It was a forward split with a ratio of 100.
| Last Split Date | Mar 27, 2014 |
| Split Type | Forward |
| Split Ratio | 100 |
Scores
NANO MRNA has an Altman Z-Score of 6.98 and a Piotroski F-Score of 2.
| Altman Z-Score | 6.98 |
| Piotroski F-Score | 2 |